Name(As of Jan 23, 2008) | 市场(资本)总值Market Cap排名 | 市场(资本)总值Market Cap | Employees排名 | Employees | 收入Revenue排名 | 收入Revenue (M) | Revenue per employee(万美圆)排名 | Revenue per employee(万美圆) | Revenue Growth排名 | Revenue Growth | Revenue Growth, 3 Years排名 | Revenue Growth, 3 Years | 企业价值Value排名 | 市盈率P/E排名 | 市盈率P/E | 年息税前利润加折旧Annual EBITDA排名 | 年息税前利润加折旧Annual EBITDA (M) | 年息税前利润加折旧per employee(万美圆)排名 | 年息税前利润加折旧per employee(万美圆) | 年息税前利润Annual EBIT排名 | 年息税前利润Annual EBIT (M) | 年息税前利润per employee(万美圆)排名 | 年息税前利润per employee(万美圆) | 每股收益EPS | EPS Change (1yr) | EPS Growth (3yr) | 毛利率Gross Margin排名 | 毛利率Gross Margin | 营运盈利率Operating Margin | 净边际利润率Net Profit Margin排名 | 净边际利润率Net Profit Margin | 现金流量Cash flows排名 | Qtrly Free Cash Flow (M) | 自由现金流量Free Cash Flow (M, 12-mos) | 杠杆Leverage排名 | 债务股本比Debt/Equity | 资产负债率Debt/Assets | LT Debt/Capital | 回报Returns排名 | 投资回报率ROI | 总资产报酬率ROA | 股本净回报率ROE |
sanofi-aventis (ADR) | 1 | 111338 | 1 | 100289 | 4 | 43044 | 75 | 42.9 | 296 | 3.4% | 101 | 50.5% | 68 | 56 | 19.1 | 1 | 24115.7 | 11 | 24.0 | 1 | 7884 | 37 | 7.9 | 2.1 | 81.5% | 3.2% | 108 | 73.3% | 15.4% | 67 | 13.2% | 576 | NA | NA | 557 | NA | NA | NA | 537 | NA | NA | NA |
Genentech, Inc. | 2 | 71252 | 10 | 10533 | 6 | 11725 | 17 | 111.3 | 188 | 26.3% | 126 | 36.4% | 52 | 72 | 26.0 | NA | NA | NA | #VALUE! | 2 | 4229 | 3 | 40.2 | 2.6 | 31.5% | 52.7% | 57 | 83.4% | 36.1% | 28 | 23.6% | 571 | NA | NA | 527 | NA | NA | NA | 515 | NA | NA | NA |
Amgen, Inc. | 3 | 48672 | 6 | 20000 | 5 | 14861 | 37 | 74.3 | 235 | 14.8% | 185 | 19.5% | 82 | 42 | 16.4 | 2 | 4803.0 | 12 | 24.0 | 3 | 3840 | 11 | 19.2 | 2.7 | -15.3% | 13.5% | 58 | 83.2% | 26.3% | 40 | 21.3% | 1 | 1282.0 | 3696.0 | 88 | 66.9 | 33.8 | 39.6 | 56 | 11.4% | 9.6% | 18.3% |
Gilead Sciences, Inc. | 4 | 41710 | 36 | 2515 | 9 | 4230 | 13 | 168.2 | 156 | 39.8% | 108 | 47.3% | 51 | 73 | 26.8 | NA | NA | NA | #VALUE! | 4 | 2165 | 2 | 86.1 | 1.7 | 229.2% | 50.3% | 68 | 81.8% | 51.2% | 15 | 38.2% | 565 | NA | NA | 486 | NA | NA | NA | 11 | 38.6% | 32.6% | 61.2% |
以上为部分内容预览